curcumin active component turmeric prevention treatment ulcerative colitis preclinical clinical observations pubmed ncbi abstract inflammatory bowel disease ibd comprising ulcerative colitis uc crohn's disease cd major ailment affecting small large bowel clinics ibd treated num amninosalicylates antibiotics steroids immunomodulators long term usages agents undue side effects compromise therapeutic advantage agents effective acceptable toxic humans preclinical studies experimental animals shown curcumin active principle indian spice turmeric curcuma longa linn effective preventing ameliorating uc inflammation decades increasing interest role curcumin ibd studies experimental models ibd shown effective mediating inhibitory effects scavenging free radicals increasing antioxidants influencing multiple signaling pathways kinases mapk erk inhibiting myeloperoxidase cox num cox num lox tnf ifn inos inhibiting transcription factor nf clinical studies shown co-administration curcumin conventional drugs effective well-tolerated treated safe medication maintaining remission prevent relapse improve clinical activity index large randomized controlled clinical investigations required fully understand potential oral curcumin treating ibd 
